EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Epigenetic reprogramming in multiple myeloma—Challenges and opportunities

Subhasree Kumar, Lev M Kats iD, Emily Gruber

International Journal of Cancer · 2026

DOI: 10.1002/ijc.35426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Subhasree Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Multiple Myeloma, Epigenesis, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leukemia and Lymphoma Society, Barrie Dalgleish Centre for Myeloma and Related Blood Cancers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In cancer, mutational processes act in concert with epigenetic reprogramming to endow malignant cells with hallmark properties that underpin tumorigenesis. Compared with the relatively rigid and slow processes of genetic evolution, the plastic nature of chromatin enables cells to adapt to a changing environment more rapidly. Multiple myeloma is characterised by high levels of inter‐ and intra‐patient heterogeneity at both the genetic and epigenetic levels. Understanding the many layers of genetic and non‐genetic evolution and their interplay is crucial to improve patient outcomes. In this short review, we discuss the most common and extensively characterised epigenetic alterations that occur during myeloma development. We also touch on emerging approaches to reverse the aberrant epigenome of myeloma cells as a treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaEpigenesis, GeneticHumansDNA MethylationCellular ReprogrammingGene Expression Regulation, NeoplasticAnimals

Stichwörter der Autor:innen

epigenetic drugsepigeneticsmultiple myeloma

Autor:innen und Institutionen

  • Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.

ORCID-Profile: Lev M Kats

Förderung

  • Leukemia and Lymphoma Society
  • Barrie Dalgleish Centre for Myeloma and Related Blood Cancers

Zitieren

APA

Kumar, S., Kats, L. M., & Gruber, E. (2026). Epigenetic reprogramming in multiple myeloma—Challenges and opportunities. International Journal of Cancer. https://doi.org/10.1002/ijc.35426

Vancouver

Kumar S, Kats LM, Gruber E. Epigenetic reprogramming in multiple myeloma—Challenges and opportunities. International Journal of Cancer. 2026. doi:10.1002/ijc.35426

BibTeX
@article{Kumar2026,
  author = {Kumar, Subhasree and Kats, Lev M and Gruber, Emily},
  title = {Epigenetic reprogramming in multiple myeloma—Challenges and opportunities},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.35426}
}
Kostenlos starten →